Description
Dapagliflozin, Glimepiride and Metformin Hydrochloride (Extended Release) Tablets MG2 is a triple-combination antidiabetic medication containing Dapagliflozin, Glimepiride, and Metformin in an extended-release formulation. It is indicated for the management of Type 2 Diabetes in adults when diet, exercise, and single-agent therapy do not provide adequate glycemic control. This combination helps lower blood glucose levels through complementary mechanisms, supporting effective and sustained diabetes management.
Dosage
Use as directed by the physician.
Indications
Management of Type 2 Diabetes Mellitus in adults
Improvement of glycemic control alongside diet and exercise
Patients requiring combination therapy with Dapagliflozin, Glimepiride, and Metformin
Long-term diabetes management under the supervision of a healthcare professional
Find answers to the most common questions about our services.